Bringing the fundamentals into focus…
Back to Dyne Therapeutics, Inc.
How Dyne Therapeutics, Inc. stacks up
DYN · against 303 other Healthcare companies of similar size
Profitability
12/ 100
Near the bottom of its peers.
Ranked #275 of 304 · scores higher than 9% of peers
Bars: peers in each 10-point band of the profitability score24 peers with a profitability score of 10–19, including DYN · Click a bar to see the companies
Why profitability scores 12?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on invested capital and return on assets, which are weaker than most Healthcare peers.
- a lower return on invested capital: weaker than 96% of peers. Return on invested capital: -188.2% vs peer median 4.7%
- a lower return on assets: weaker than 73% of peers. Return on assets: -7.4% vs peer median 1.7%
- Operating margin is not reported, so it is left out of the score.
Metric by metric
Position: dot = DYN, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | DYN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 295 reported | -188.2% | 7.4% | 2% | 33% | |
| Operating marginHigher is better · 280 reported | Not reported | 9.8% | — | — | 33% |
| Return on assetsHigher is better · 287 reported | -7.4% | 2.7% | 24% | 33% | |
| Return on equityHigher is better · 282 reported | -81.6% | 6.9% | 8% | Context only | |
| Gross marginHigher is better · 311 reported | 0.0% | 47.6% | 3% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around DYN| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 4 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 4 | 51.3B ZAR (≈$2.8B) | 99 | 73 | |
| 268 | 2.3B USD | 14 | 27 | |
| 272 | 3.7B USD | 13 | 31 | |
| 272 | 5.7B USD | 13 | 30 | |
| 272 | 3.9B USD | 13 | 52 | |
| 275 | 3.4B USD | 12 | 35 | |
| 275 | 5.1B USD | 12 | 35 | |
| 275 | 2.2B USD | 12 | 35 | |
| 278 | 2.2B USD | 11 | 48 | |
| 279 | 3.9B USD | 10 | 47 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score